Skip to main content
. 2023 Jul 5;6(2):113–122. doi: 10.26828/cannabis/2023/000125

Table 1.

Cannabis-Only and Cannabis + Opioids Users Enrolled in the OAPP

Cannabis only Co-users p-value
Total Sample N=450 N (%) N (%)
N=73 (16.2) N=377 (83.8)
Attitudes & experiences
Believe cannabis use is risky 9 (12.3) 52 (13.8) 0.883
Believe opioid use is risky 73 (100.0) 335 (88.9) 0.006
Had a negative opioid experience 47 (64.4) 209 (55.4) 0.199
Know someone who had a negative opioid experience 53 (72.6) 207 (54.9) 0.008
Reason for using cannabis <0.001
I will use in addition to my current opioids 0 (0.0) 16 (4.2)
To reduce my current use of opioids 0 (0.0) 108 (28.6)
To replace and stop my use of opioids 3 (4.1) 113 (30.0)
To avoid prescription opioid medications altogether 70 (95.9) 140 (37.1)
Medical Conditions
Osteoarthritis 18 (24.7) 92 (24.4) 1
Spinal Conditions/Back Pain 33 (45.2) 222 (58.9) 0.042
Chronic Pain 45 (61.6) 249 (66.0) 0.556
Othera 13 (17.8) 64 (17.0) 0.998
Symptoms
Sleep problems 31 (42.5) 182 (48.3) 0.434
Emotional problems 20 (27.4) 91 (24.1) 0.658
Digestive problems 7 (9.6) 54 (14.3) 0.371
Pain Level (mean (SD)) 54.9 (25.1) 60.8 (21.4) 0.04
Demographics
Age: 65 years and older 21 (28.8) 121 (32.1) 0.673
Sex: Female 29 (39.7) 194 (51.5) 0.088
Education: College or higher degree 34 (46.6) 159 (42.2) 0.571
Employed 42 (57.5) 176 (46.7) 0.116
Financially secure 54 (74.0) 231 (61.3) 0.054
Type of provider who provided cannabis certification <0.001
General Practitioner 28 (38.4) 151 (40.1)
Pain Specialist 18 (24.7) 163 (43.2)
Other specialist 27 (37.0) 63 (16.7)
Certifying physician was a routine provider 50 (68.5) 321 (85.1) 0.001
a

Cancer, rheumatoid arthritis, multiple sclerosis, fibromyalgia.